New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Tezspire Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...

Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...

Key Takeaways A pediatric allergy specialist says babies should explore allergenic foods around 4 to 6 months of ageFeeding ...

Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma inhalers, are not ...

A new study published in The Journal of Allergy and Clinical Immunology showed that macrolide treatment probably improves ...

This is Colossus: a data center that Musk’s artificial-intelligence company, xAI, is using as a training ground for Grok, one ...

Randomized trial does hint at benefit for several individual food allergies ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...